Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000944809-26-000002
Filing Date
2026-08-07
Accepted
2026-08-07 19:49:47
Documents
4
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 21332
2 OPKO DIRECTORS AND EXECUTIVE OFFICERS SC1.pdf EX-1 16189
3 EXHIBIT 2 JFA.pdf EX-2 10499
4 EXHIBIT 4 POA.pdf EX-4 12586
  Complete submission text file 0000944809-26-000002.txt   78072
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filed by) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Subject) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-87608 | Film No.: 261255898
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)